LINCOLN

What Lincoln Pharmaceuticals promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q3 FY26

what the last two calls moved 12 tracked 0 delivered 0 missed 12 open
  • Revenue Growth Pace open said Q3 FY26 Promised: 12% to 18% Q3 FY26: Q3 FY26 YoY growth was 13.49%, falling within the target range.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 12 tracked commitments for Lincoln Pharmaceuticals — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens